by Sue Robbins | Feb 10, 2020 | Migraine
Migraine and severe headache affect an estimated 15% of the US population, with prevalence rates twice as high in women as in men.1 These patients often face significant disability and debilitating symptoms; common comorbidities such as insomnia and psychiatric...
by Sue Robbins | Feb 7, 2020 | Miscellaneous
Craniosacral therapy (CST) may have major therapeutic benefits to those suffering from chronic pain, a new literature review published in BMC Musculoskeletal Disorders found. The literature review examined randomized controlled trials for craniosacral therapy (CST) in...
by Sue Robbins | Feb 5, 2020 | Migraine
Adults with Migraine have new reason to be hopeful. 2019 saw FDA approval of new acute Migraine medications, and 2020 will be the year thousands of adults with Migraine with or without aura will get to try new meds like Ubrelvy (ubreogepant). Ubrelvy is an oral CGRP...
by Sue Robbins | Feb 2, 2020 | Migraine
Active meditative techniques appear to be more effective at reducing migraine severity than distraction techniques, according to research published in the journal Complementary Therapies in Medicine. “Meditation practice has been associated with improved pain...
by Sue Robbins | Jan 30, 2020 | Headache Drugs
Excedrin migraine medications are some of the most commonly used drugs to treat migraine headaches. However, people who suffer from the intense, painful headaches may have to try new treatments for a bit. Manufacturer GlaxoSmithKline (GSK) has temporarily halted...
